3D-cultured adipose stem cell vesicles and diabetic wound healing in cells, mice and pigs
In this abstract, extracellular vesicles from 3D-cultured adipose stem cells reduced senescence markers in high-glucose human microvascular endothelial cells and sped wound closure in diabetic mice and pigs; the pig comparison was against conventional adipose stem cell vesicles. [1]
Automatic summary · not editorially reviewed
The key findings
The study focused on senescence of human dermal microvascular endothelial cells and used a self-feeder layer 3D culture system to prepare three-dimensional adipose stem cells and their extracellular vesicles. [1]
In high-glucose-treated human microvascular endothelial cells, the vesicles reduced senescence, oxidative stress and mitochondrial dysfunction and increased tube formation. [1]
In a diabetic Bama miniature pig model, the vesicles showed better wound closure, vessel density, scar width and collagen orderliness than conventional adipose stem cell vesicles. [1]
The source at a glance
- Study type / format
- Preclinical laboratory and animal study (abstract)
- Population / context
- Human dermal microvascular endothelial cells in culture, diabetic mice and diabetic Bama miniature pigs
- Summary based on
- Study abstract
- Original publication
- June 22, 2026
Senescent microvascular cells as the study target
The abstract frames diabetic foot ulcers as severe diabetes complications with limited treatment options. It says earlier work on impaired blood vessel formation relied on generic endothelial cells that poorly reflect the diabetic microvasculature. This study therefore focused on senescence of human dermal microvascular endothelial cells. The authors used a self-feeder layer 3D culture system to reprogram adipose-derived mesenchymal stem cells into three-dimensional adipose stem cells and to prepare their extracellular vesicles.
Supporting source [1]
Cell and animal observations on vesicles
In high-glucose-treated human microvascular endothelial cells, the vesicles reduced senescence, oxidative stress and mitochondrial dysfunction and increased tube formation. The authors report activation of PI3K/AKT/mTOR signaling, more phosphorylated 4EBP1 and assembly of eIF4E with eIF4G; inhibitors and a phosphorylation-mimetic 4EBP1 plasmid were used to test this pathway. In diabetic mice, the vesicles accelerated wound closure and raised microvascular density, alongside lower p16 and higher CD31 and p-4EBP1 expression. In a diabetic Bama miniature pig model, the vesicles performed better than conventional adipose stem cell vesicles on wound closure, vessel density, scar width and collagen orderliness.
Supporting source [1]
Preclinical scope of the reported evidence
The abstract describes laboratory cell experiments and animal models, not treatment of people with diabetic foot ulcers. The pig comparison was between the two vesicle types, and the abstract does not report sample sizes, follow-up durations or statistical uncertainty. The authors conclude that the vesicles improved healing by targeting endothelial senescence through the described translational pathway and call this a therapeutic potential; these are preclinical findings, not proof of benefit in patients.
Supporting source [1]
How to interpret this
This is an abstract; the full text was not reviewed. It reports laboratory cell work and animal models, without sample sizes, follow-up or statistical uncertainty, and does not show benefit in people with diabetic foot ulcers.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang Y, Hu Z, Shi A, Cao P, Zhao L, Di X, Kang Y, Wang J, Gong L, Chen W, Wang G, Cao G, Luo L, Zhao R, Zhang X, Liu Y. · europepmc.org · June 22, 2026